Cytokinetics, Incorporated
Cytokinetics, Incorporated（CYTK）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cytk · 股价预测 · 35 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 35 位华尔街分析师
Buy
35 位分析师
共识
评级分布
12 个月目标价
High
$140
Consensus
$99.92
+45.2% upside
Low
$83.00
Median: $99 · Last Close: $68.81
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$99.92
45.2% upside
High Target
$140
103.5%
Low Target
$83
20.6%
Current Price
$68.81
as of today
Based on analyst price targets, the CYTK stock price prediction for the next 12 months ranges from $83 to $140. The consensus CYTK price forecast of $99.92 implies 45.2% upside from the current price of $68.81.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $66.24 | ↓ 3.74% |
1-day model range: $65.75–$66.73. Peak: $66.73 (-3.74%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CYTK · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-07 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-06 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-06 | Stifel | Maintains | Buy→Buy |
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-04-06 | Barclays | Maintains | Overweight→Overweight |
| 2026-03-18 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-17 | JP Morgan | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cytokinetics, Incorporated (CYTK) stock. Of the recent 217 rating actions, 5 were upgrades and 9 were downgrades. 35 analysts currently cover CYTK.
分析师推荐趋势
CYTK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 8 to 7 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$105M
↓ 88.0% YoY
Revenue Next Year
$388M
↑ 268.0% YoY
EPS This Year
$-6.38
EPS Next Year
$-4.59
↓ 28.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast CYTK EPS of $-6.38 for the current fiscal year, based on estimates from 15 analysts. The CYTK revenue forecast is $105M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CYTK 股价预测由两类独立数据源支撑：来自 35 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CYTK 的共识目标价为 $99.92（+45.2% 上行空间），分析师共识为 Buy。
CYTK 的短期预测（明日）为 $66.24（-3.74%）。
Cytokinetics, Incorporated 在 NASDAQ 上市，代码 CYTK。CYTK 在 2027 年的整体展望偏积极，在覆盖分析师中约 94% 对应 Buy 共识。
常见问题
CYTK 预测 · 8 个问题根据 35 位华尔街分析师，CYTK 的 12 个月平均目标价为 $99.92，最高 $140.00、最低 $83.00。若有图表，中位目标价可在上方查看。相对当前价 $68.81，隐含约 +45.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.